Resuscitation Devices Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Resuscitation Devices Market Report Segments the Industry by Product Type (Airway Management Devices [Endotracheal Tubes, and More], External Defibrillators, Convective Warming Blankets), Patient Type (Adult, Pediatric, and Neonatal), End User (Hospitals, and More), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, South America). The Market Forecasts are Provided in Terms of Value (USD).

Resuscitation Devices Market Size and Share

Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Compare market size and growth of Resuscitation Devices Market with other markets in Healthcare Industry

Resuscitation Devices Market Analysis by Mordor Intelligence

The Resuscitation Devices Market size is estimated at USD 6.02 billion in 2025, and is expected to reach USD 7.99 billion by 2030, at a CAGR of 5.84% during the forecast period (2025-2030).

Growing cardiopulmonary disease prevalence, government-backed public-access defibrillation programs, and rapid adoption of AI-integrated airway and defibrillation systems underpin this steady expansion. North America’s mature reimbursement ecosystem, mandatory AED deployment in transportation hubs, and federal funding for emergency medical services sustain premium device demand. Meanwhile, Asia-Pacific’s 9.13% CAGR reflects supportive industrial policies, ISO regulatory alignment, and extensive public-private investment in indigenous manufacturing capacity. On the product front, single-use airway management devices gain traction as infection-control imperatives remain top of mind, and AI-enabled wearable cardioverter defibrillators open home-care revenue streams. Competitive dynamics feature moderate fragmentation, with leading firms divesting non-core assets and acquiring niche technologies to sharpen clinical relevance and expand connected-care portfolios.

Key Report Takeaways

  • By product type, airway management devices captured 41.33% of resuscitation devices market share in 2024, while wearable cardioverter defibrillators are forecast to expand at a 10.17% CAGR to 2030. 
  • By patient type, adult patients held 65.19% of the resuscitation devices market size in 2024; neonatal applications are advancing at an 8.25% CAGR through 2030. 
  • By end user, hospitals dominated with 56.94% revenue share in 2024, whereas home care is projected to grow at a 7.69% CAGR over the same period. 
  • By geography, North America led with 37.43% share of the resuscitation devices market in 2024, while Asia-Pacific records the fastest regional CAGR at 9.13% through 2030.

Segment Analysis

By Product Type: Airway Management Dominance Amid Wearable Innovation

Airway management devices held 41.33% of resuscitation devices market share in 2024, anchored by the clinical indispensability of extraglottic airways and improved disposable bag-valve-mask technology. The segment’s forecast expansion relies on ergonomic designs that cut intubation time and AI-guided ventilator settings personalized to patient physiology. Endotracheal tubes retain primacy under complex trauma but share protocols increasingly with i-gel and laryngeal masks for rapid deployment scenarios. External defibrillators form the second-largest cluster, with the wearable cardioverter subcategory posting a 10.17% CAGR as AI analytics allow real-time rhythm surveillance during everyday activities. Convective warming blankets continue to prove superior to resistive pads in preventing hypothermia during trauma resuscitation, supporting steady demand in emergency departments.

Across these offerings, the resuscitation devices market size for airway solutions is projected to rise at a mid-single-digit CAGR in line with procedure volumes and infection-control policies. Continuous material science improvements, such as PVC-free and phthalate-free polymers, enhance product safety and win institutional tenders. Meanwhile, fully automated public-access AEDs reduce user hesitation through voice prompts and shock authorization algorithms, accelerating placements in airports and shopping centers.

Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

By Patient Type: Adult Dominance with Neonatal Growth Acceleration

Adults represent 65.19% of the resuscitation devices market size in 2024, thanks to higher cardiovascular event prevalence and stricter workplace AED mandates. Machine-learning-powered rhythm classifiers raise first-shock efficacy, while personal defibrillators like CellAED address the fact that 80% of sudden cardiac arrests occur at home. Pediatric indications stay consistent, employing age-appropriate energy settings and weight-specific airway interfaces. Geriatric considerations now influence design language, bigger screens, haptic alerts, and simplified battery swaps to accommodate declining dexterity.

Neonatal applications exhibit the fastest trajectory at 8.25% CAGR to 2030, owing to rising survival ambitions in perinatal asphyxia cases. Innovative chest-compression-plus-sustained-inflation protocols seek FDA IDE approval and could spur specialized hardware sales. Nasal masks gain ground over prongs, lowering complication rates and influencing purchasing guidelines. Non-contact optical sensors are trialed to curb skin breakdown and infection. Taken together, these advances position neonatology as an outsized value-creation arena for next-generation vendors.

By End User: Hospital Leadership Amid Home-Care Surge

Hospitals captured 56.94% share of the resuscitation devices market in 2024, leveraging comprehensive code-blue readiness mandates and multi-disciplinary trauma teams. Integration with EMR platforms and fleet dashboards supports predictive maintenance, while automated chest-compression systems safeguard CPR quality during long transports. Ambulatory surgical centers favor compact defibrillators with cloud connectivity that maximize limited storage footprints. Specialty cardiology clinics invest in AI-driven diagnostic defibrillators that sync arrhythmia data to patient portals for seamless follow-up.

Home care ranks as the fastest-growing channel at 7.69% CAGR due to aging-in-place preferences and user-friendly, app-guided devices. Cloud-native architectures slash unit costs; BioT shows that connected monitors can be produced for USD 200 instead of USD 20,000, unlocking broader consumer access. Remote device readiness checks ensure pads are within expiry and batteries topped, while tele-guidance functions coach lay responders in real time. The segment’s rise aligns with broader healthcare decentralization that prioritizes immediate, location-agnostic intervention.

Market Share by End User
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

Geography Analysis

North America’s 37.43% revenue leadership in 2024 stems from robust bystander training initiatives and legally mandated AED presence in public venues. Federal grants subsidize equipment replacement every five years, fostering a vibrant aftermarket. Market incumbents such as ZOLL and Stryker introduce Wi-Fi-enabled defibrillators that transmit event data directly into quality-assurance registries, supporting continuous protocol refinement. Canada invests in provincial trauma-network upgrades, while Mexico streamlines regulatory pathways to stimulate domestic manufacturing.

Asia-Pacific is the fastest-expanding territory, posting a 9.13% CAGR supported by India’s vision to build a medical device sector by 2030. Production-Linked Incentive schemes and medical device park clusters lower entry barriers for foreign firms tapping local demand. Japan aligns its QMS with ISO 13485:2016, easing CE-to-PMDA conversions and prompting launches like Canon’s fully automatic AED that eliminates shock-decision overwhelm. China tackles low AED fluency through nationwide CPR curricula, while Australia funds rural drone-AED pilots to improve golden-minute access.

Europe maintains steady incremental growth, propelled by cross-border regulatory convergence under the Medical Device Regulation and national health systems that refresh fleets on fixed cycles. South America benefits from hospital construction booms, especially in Brazil, although currency volatility tempers import volumes. Middle East & Africa unlock opportunity through medical-tourism corridors, with Gulf Cooperation Council hospitals adopting premium connected ventilators. Globally, manufacturers diversify supply chains from China toward Vietnam and Thailand to buffer geopolitical tension, a trend mirrored in rare-earth magnet sourcing strategies.

Growth Rate by Region
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Competitive Landscape

The resuscitation devices industry exhibits moderate fragmentation. Philips’ sale of its Emergency Care business to Bridgefield Capital illustrates a pivot toward higher-margin imaging and informatics, yet Philips retains a 15-year brand-licensing arrangement to protect installed-base loyalty. ZOLL’s purchase of Vyaire Medical’s ventilator division strengthens its respiratory continuum and fortifies cross-selling into defibrillator accounts. Drägerwerk integrates AI-enabled ventilator algorithms co-developed with university hospitals to differentiate in clinical decision support.

Medtronic’s PulseSelect pulsed-field ablation system and ultra-slim OmniaSecure lead expand its electrophysiology suite, positioning the firm for bundled arrhythmia care strategies. Stryker’s LIFEPAK 35 adds cloud log-sync and remote service diagnostics to compress field downtime. Start-ups attack white spaces: CellAED pursues consumer self-defibrillation; 410 Medical scales rapid-fluid resuscitation devices following a USD 14 million Series B; and CPR Therapeutics’ multimodal system merges hemodynamic feedback with defibrillation to optimize resuscitation.

Regulatory overhead shifts competitive calculus. Higher user fees and active-surveillance mandates advantage capital-rich incumbents over niche vendors. Supply-chain diversification also shapes strategy as capacitor-grade rare-earth magnet volatility forces procurement hedging; Neo Performance Materials reported revenue declines in Q3 2024 driven by medical-device demand weakness, signaling broader raw-material exposure. Overall, technology convergence, portfolio pruning, and manufacturing relocation define the go-forward playbook.

Resuscitation Devices Industry Leaders

  1. Drägerwerk AG & Co. KGaA

  2. Koninklijke Philips N.V

  3. Medtronic

  4. ZOLL Medical

  5. Mindray Bio-Medical

  6. *Disclaimer: Major Players sorted in no particular order
Resuscitation Devices Market
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.
Need More Details on Market Players and Competitors?
Download PDF

Recent Industry Developments

  • May 2025: 410 Medical, Inc., a medical device company specializing in breakthrough technologies for emergency and critical care, has completed a USD 14 million Series B financing round. The funding was led by existing investor Hatteras Venture Partners, with strong participation from a coalition of strategic partners including Orlando Health Ventures, Ballad Ventures, OSF Healthcare, WakeMed, Rex Health Ventures, CU Healthcare Innovations Fund, and Sarnova. This capital infusion will support the company’s ongoing efforts to scale product adoption, expand clinical evidence, and drive innovation in rapid fluid resuscitation technologies.
  • March 2025: CPR Therapeutics Inc., an early-stage medical device start-up backed by the NSF and NIH, has received a continuation U.S. patent (US12,285,621) for its groundbreaking multimodal cardiopulmonary resuscitation (CPR) system. The patented technology - "Automated Resuscitation System Integrating Hemodynamic and Defibrillatory Capabilities"—underpins a novel device designed for emergency use.
  • January 2025: Philips announced the sale of its Emergency Care business to Bridgefield Capital, including automated external defibrillators and critical care products, with completion expected in the second half of 2025 pending regulatory approval. This strategic divestment allows Philips to focus on areas with greater financial impact while maintaining 15-year brand licensing rights
  • September 2024: Medtronic launched the VitalFlow ECMO system, designed to enhance bedside care and intra-hospital transport, featuring a large touch screen for real-time data and a portable design for efficient use across hospital departments. The system stems from Medtronic's acquisition of MC3 Cardiopulmonary and addresses clinicians' needs for user-friendly ECMO solutions.
  • June 2024: Stryker launched the LIFEPAK 35 monitor/defibrillator designed to reduce caregiver burden and enhance workflow for emergency responders, featuring advanced technology, real-time patient information access, and a user-friendly interface with trend monitoring capabilities.

Table of Contents for Resuscitation Devices Industry Report

1. Introduction

  • 1.1 Study Assumptions & Market Definition
  • 1.2 Scope of the Study

2. Research Methodology

3. Executive Summary

4. Market Landscape

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Escalating Global Cardiopulmonary Disease Burden
    • 4.2.2 Rising Demand for Pre-Hospital Emergency Response Systems
    • 4.2.3 AI-Enabled Monitoring & Decision-Support Integration
    • 4.2.4 Disposable Airway Products for Infection-Control Mandates
    • 4.2.5 Government Mandates for Public-Access AEDs in Transit Hubs
    • 4.2.6 Cloud-Connected Device-Fleet Management and Analytics
  • 4.3 Market Restraints
    • 4.3.1 Neonatal Device-Related Barotrauma and Lung Injury
    • 4.3.2 Burdensome Product-Recall & Post-Market Surveillance Costs
    • 4.3.3 Cybersecurity Risks In Connected Defibrillators
    • 4.3.4 Rare-Earth Magnet Supply Volatility for Capacitor Modules
  • 4.4 Technological Outlook
  • 4.5 Porter’s Five Forces Analysis
    • 4.5.1 Threat of New Entrants
    • 4.5.2 Bargaining Power of Buyers
    • 4.5.3 Bargaining Power of Suppliers
    • 4.5.4 Threat of Substitutes
    • 4.5.5 Intensity of Competitive Rivalry

5. Market Size & Growth Forecasts (Value in USD)

  • 5.1 By Product Type
    • 5.1.1 Airway Management Devices
    • 5.1.1.1 Endotracheal Tubes
    • 5.1.1.2 Tracheostomy Tubes
    • 5.1.1.3 Mechanical Ventilators
    • 5.1.1.4 Resuscitators (BVM)
    • 5.1.1.5 Others
    • 5.1.2 External Defibrillators
    • 5.1.2.1 Fully Automated AEDs
    • 5.1.2.2 Semi-Automated AEDs
    • 5.1.2.3 Wearable Cardioverter Defibrillators
    • 5.1.3 Convective Warming Blankets
  • 5.2 By Patient Type
    • 5.2.1 Adult
    • 5.2.2 Pediatric
    • 5.2.3 Neonatal
  • 5.3 By End User
    • 5.3.1 Hospitals
    • 5.3.2 Ambulatory Surgical & Emergency Centers
    • 5.3.3 Speciality Clinics
    • 5.3.4 Home Care Settings
  • 5.4 By Geography
    • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
    • 5.4.2 Europe
    • 5.4.2.1 Germany
    • 5.4.2.2 United Kingdom
    • 5.4.2.3 France
    • 5.4.2.4 Italy
    • 5.4.2.5 Spain
    • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 Japan
    • 5.4.3.3 India
    • 5.4.3.4 Australia
    • 5.4.3.5 South Korea
    • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East & Africa
    • 5.4.4.1 GCC
    • 5.4.4.2 South Africa
    • 5.4.4.3 Rest of Middle East & Africa
    • 5.4.5 South America
    • 5.4.5.1 Brazil
    • 5.4.5.2 Argentina
    • 5.4.5.3 Rest of South America

6. Competitive Landscape

  • 6.1 Market Concentration
  • 6.2 Market Share Analysis
  • 6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
    • 6.3.1 Drägerwerk AG & Co. KGaA
    • 6.3.2 Koninklijke Philips N.V.
    • 6.3.3 ZOLL Medical
    • 6.3.4 Medtronic plc
    • 6.3.5 Stryker Corporation
    • 6.3.6 GE HealthCare Technologies
    • 6.3.7 Nihon Kohden Corporation
    • 6.3.8 Mindray Bio-Medical
    • 6.3.9 Smiths Medical (ICU Medical)
    • 6.3.10 Cardinal Health
    • 6.3.11 ResMed Inc.
    • 6.3.12 Ambu A/S
    • 6.3.13 Laerdal Medical
    • 6.3.14 Teleflex Inc.
    • 6.3.15 Fisher & Paykel Healthcare
    • 6.3.16 Intersurgical Ltd
    • 6.3.17 Hamilton Medical AG
    • 6.3.18 Becton Dickinson & Co.
    • 6.3.19 Ventec Life Systems
    • 6.3.20 Air Liquide Medical Systems

7. Market Opportunities & Future Outlook

  • 7.1 White-space & Unmet-Need Assessment
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Global Resuscitation Devices Market Report Scope

As per the scope, Resuscitation devices aim to initiate spontaneous breathing by mechanically ventilating the lungs. These devices maneuvers optimize tissue uptake of oxygen, improve oxygen delivery, and preserve the metabolic rate of oxygen. Resuscitation Devices Market is segmented By Product Type, End-User and Geography.

By Product Type Airway Management Devices Endotracheal Tubes
Tracheostomy Tubes
Mechanical Ventilators
Resuscitators (BVM)
Others
External Defibrillators Fully Automated AEDs
Semi-Automated AEDs
Wearable Cardioverter Defibrillators
Convective Warming Blankets
By Patient Type Adult
Pediatric
Neonatal
By End User Hospitals
Ambulatory Surgical & Emergency Centers
Speciality Clinics
Home Care Settings
By Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa GCC
South Africa
Rest of Middle East & Africa
South America Brazil
Argentina
Rest of South America
By Product Type
Airway Management Devices Endotracheal Tubes
Tracheostomy Tubes
Mechanical Ventilators
Resuscitators (BVM)
Others
External Defibrillators Fully Automated AEDs
Semi-Automated AEDs
Wearable Cardioverter Defibrillators
Convective Warming Blankets
By Patient Type
Adult
Pediatric
Neonatal
By End User
Hospitals
Ambulatory Surgical & Emergency Centers
Speciality Clinics
Home Care Settings
By Geography
North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa GCC
South Africa
Rest of Middle East & Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Key Questions Answered in the Report

What is the current value of the resuscitation devices market?

The resuscitation devices market is worth USD 6.02 billion in 2025 and is forecast to reach USD 7.99 billion by 2030, growing at a 5.84% CAGR.

Which segment holds the largest share of the market?

Airway management devices lead with 41.33% resuscitation devices market share in 2024 due to their indispensability in emergency protocols.

Which region is growing the fastest?

Asia-Pacific records the highest regional CAGR at 9.13% through 2030, supported by industrial incentives in India and regulatory alignment in Japan.

Why are wearable cardioverter defibrillators gaining popularity?

Wearable cardioverter defibrillators are expanding at a 10.17% CAGR because AI-enabled monitoring allows continuous rhythm analysis, particularly valuable in home-care settings.

How are infection-control policies shaping product design?

Post-COVID guidelines have accelerated adoption of single-use airway devices, prompting manufacturers to develop PVC-free disposable resuscitators that minimize cross-contamination.

What challenges do manufacturers face with connected devices?

Cybersecurity threats and heightened post-market surveillance obligations increase compliance costs and necessitate robust software patch management across connected defibrillator fleets.

Page last updated on: June 23, 2025

Resuscitation Devices Market Report Snapshots